Side-by-side comparison
Anamorelin vs KPV
Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz. versus Anti-inflammatory tripeptide derived from α-MSH; gut and skin healing without sedation.
Anamorelin
PerformanceOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Top benefits
- ✓Increases lean body mass
- ✓Improves appetite
- ✓Oral bioavailability
KPV
RecoveryAnti-inflammatory tripeptide derived from α-MSH; gut and skin healing without sedation.
Top benefits
- ✓Reduces inflammation
- ✓Gut healing (UC/IBD studies)
- ✓Wound and acne support
| Attribute | Anamorelin | KPV |
|---|---|---|
| Category | Performance | Recovery |
| Type | small-molecule | linear |
| Chain length | 1 aa | 3 aa |
| Formula | C31H42N6O3 | C18H34N6O4 |
| Common dose | 100 mg | 200–500 mcg |
| Frequency | Daily, oral | Daily |
| Top benefit | Increases lean body mass | Reduces inflammation |
| Top side-effect | Hyperglycemia | Minimal reported |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.